Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study
Abstract Background This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the US, through claims data. Methods SCD patients with pharmacy claims for HU were selected from the Medicaid Analytic Extracts (MAX) from J...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2019-10-01
|
| Серія: | Health and Quality of Life Outcomes |
| Предмети: | |
| Онлайн доступ: | http://link.springer.com/article/10.1186/s12955-019-1225-7 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|